SCHEMBL21236712

SCHEMBL21236712

O=CNc1cn(CCc2ccccc2)nc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 12/20 0.44
ADORA1 P30542 11/20 0.44
ADORA3 P0DMS8 10/20 0.44
HDAC2 Q92769 3/20 0.39
ADORA2B P29275 1/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
KDM4E B2RXH2 1/20 0.39
KDM6B O15054 1/20 0.39
KDM4A O75164 1/20 0.39
KDM5C P41229 1/20 0.39
KDM4C Q9H3R0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21236762 0.88 ADORA3 (0.43) ADORA2AADORA1ADORA3ADORA2BKDM4E
SCHEMBL16578613 0.74 ADORA2A (0.46) ADORA2AADORA1ADORA3HDAC2ADORA2B
SCHEMBL3467509 0.72 ADORA2A (0.47) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL23005604 0.72 MEN1 (0.53) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL1875570 0.72 KMT2A (0.48) ADORA2AADORA1ADORA3
SCHEMBL12671226 0.72 MEN1 (0.50) ADORA2AADORA1ADORA3KDM4EKDM6B
SCHEMBL21224988 0.71 KMT2A (0.47) ADORA2AADORA1ADORA3
SCHEMBL21225118 0.71 KMT2A (0.47) ADORA2AADORA1ADORA3
SCHEMBL21225109 0.71 KMT2A (0.47) ADORA2AADORA1ADORA3
SCHEMBL17023211 0.71 ADORA3 (0.37) ADORA2AADORA1ADORA3KDM4EKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019152546-A2 SALT FORMS OF ORGANIC COMPOUND KAINOS MEDICINE INC. (KR) 2019-08-08 WO disclosed